Research desk · CSCIF · OTC
CSCIF Stock
SEC financials, peer compare, and chart. Scores open the matching desk. Research only — not advice.
COSCIENS Biopharma Inc. · Perfumes, Cosmetics & Other Toilet Preparations
COSCIENS Biopharma Inc. financial statements, chart, and peer compare from SEC filings.
COSCIENS Biopharma Inc. (CSCIF) operates in Perfumes, Cosmetics & Other Toilet Preparations.
- Market cap
- $16.41M
- P/E
- —
- Op. margin
- -142.45%
- Profit margin
- -138.14%
- FCF margin
- -122.42%
- ROE
- -269.60%
Related Consumer Staples stocks: AXIL stock financials · BNC stock financials · BNCWW stock financials · BNCWZ stock financials · MWYN stock financials
CSCIF financial statements
Each Compare name is its own block of years. Filing lines are SEC reports; P/E and price sit on that name’s TTM column only.
CSCIF stock peer compare
Each bar is that name’s percent vs its last TTM, on one zero line. Zero is unchanged. This ticker is the black bar.
Focus chart
Zero is unchanged vs last TTM. Every name is a percent for the metric you pick.
CSCIF stock peer headlines
Yahoo Finance RSS for CSCIF and the names in Compare.
| Ticker | Date | Headline |
|---|---|---|
| Loading headlines… | ||
CSCIF stock price chart
Overlays follow the Compare table.
CSCIF stock — research snapshot
Screen strengths and watchouts for CSCIF stock from the latest Misprise snapshot.
Strengths
- Revenue CAGR 5Y 15.5% — durable top-line compound.
- EPS CAGR 5Y 93.7% — earnings compounding.
- Debt/equity 0.00 — leverage looks manageable.
- Current ratio 3.18 — liquidity cushion.
Watchouts
- ROA -48.3% — muted asset returns.
- ROE -269.6% — soft equity returns.
- Operating margin -142.5% — thin operating cushion.
- Negative profit margin — earnings quality needs scrutiny.
- Negative FCF margin — cash generation is under pressure.
- Rev CAGR 5Y 15.5%
- Rev CAGR 3Y -19.9%
- EPS CAGR 5Y 93.7%
- EPS CAGR 3Y —
- FCF CAGR 5Y 17.3%
- FCF CAGR 3Y —
CSCIF stock FAQs
Short answers for CSCIF stock — statements, sector, and how this page is meant to be used.
What is CSCIF stock?
COSCIENS Biopharma Inc. (CSCIF) operates in Perfumes, Cosmetics & Other Toilet Preparations. CSCIF stock sits in Consumer Staples (Perfumes, Cosmetics & Other Toilet Preparations), listed on OTC.
Where can I find COSCIENS Biopharma Inc. financial statements?
COSCIENS Biopharma Inc. financial statements — income statement, balance sheet, and cash flow — are on this CSCIF stock page, parsed from SEC 10-K and 10-Q filings. Use Annual or Quarterly, then the statement tabs. Research only.
What happened to CSCIF stock?
This page is a research snapshot of COSCIENS Biopharma Inc. (CSCIF) from the latest SEC filings in the Misprise database as of FY2025. It is not a news feed or a delisting notice. Open the financial statements, chart, and peer compare below, then read the filings. Research only — not financial advice.
Does this page show the CSCIF stock price?
The live chart on this CSCIF stock page is the same TradingView chart as the screener. Statement tables use SEC filings. Any price or multiple on the TTM column is a market snapshot from the last seed, not a real-time quote. Research only.
What sector is CSCIF stock in?
COSCIENS Biopharma Inc. is classified in Perfumes, Cosmetics & Other Toilet Preparations, inside the Consumer Staples sector, and trades on OTC. This page is a research snapshot, not a full company profile.
How do I read CSCIF financial statements?
Start with this ticker’s block (TTM, then its fiscal years or quarters). Each Compare name is a separate block of its own periods — not mixed by year. A blank is a period we do not have, not a zero. Research only — not a buy or sell.
Where does the CSCIF statement data come from?
Income, balance sheet, and cash-flow lines are parsed from SEC company filings (10-K / 10-Q and 20-F). TTM is the last four reported quarters added together, not a separate filing. P/E, forward P/E, price, and market cap are a market quote at last seed — trailing P/E from the quote when available, otherwise last price divided by TTM EPS. They are not 10-K line items and appear on the TTM column only. Research only — not financial advice.
Where can I find the CSCIF income statement, balance sheet, and cash flow?
On this CSCIF stock page, open Financial statements and use the Income, Balance sheet, and Cash flow tabs. Growth and valuation sit under More. Filing figures are from SEC reports; valuation multiples are the market snapshot described above.
What is the Misprise Score for CSCIF stock?
CSCIF stock currently scores 0/100 (Watch / incomplete (<60)). COSCIENS Biopharma Inc. scores weaker or incomplete on durable growth/quality inputs — leverage, coverage, and recent results deserve extra scrutiny. The score is a screen of quality, growth, and balance-sheet inputs — not a price target. Compare it in the Misprise screener; it is not a separate score page.
How is the CSCIF comparison winner decided?
Lead and Tie follow the number printed on each factor row, not a blended category score. Growth, quality, score, current ratio, and coverage: the higher figure leads. Value multiples (P/E, PEG, P/B, P/S) and debt ratios: the lower figure leads. Tie appears only when those printed numbers match. The header winner is whoever takes more of those five rows. CAGR uses the 5-year horizon and drops to 3-year only when both names report it. Research only — not a buy or sell.
What is the Anomaly Score on this CSCIF page?
Anomaly Score is how unusual a filing pattern is versus this company’s own history and its industry — not the same as Misprise Score. A high anomaly with a weak Misprise Score is often a noisy name. Open the anomaly detector to see the flag. Research only — not financial advice.
What does the green grant dot mean on CSCIF stock?
A green circle next to the title means this ticker appears in the Misprise grants calendar with a recent federal award (USASpending / SAM). Tap the dot for date, agency, and amount when available. It is a research flag only — not a buy or sell signal.
Is CSCIF stock a buy?
No recommendation either way. This CSCIF stock page organizes statements, ratios, and peers so you can do your own work. It is educational only — not advice to buy or sell COSCIENS Biopharma Inc..